Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

2.3. Reagents

MH Ming-Feng Hou
FO Fu Ou-Yang
HY Hon-Kan Yip
CL Chi-Wen Luo
ask Ask a question
Favorite

Antibodies against VEGFR2 (#2479), cyclin D1 (#2978S), cyclin B1 (#4135S), FAK (#3285, 1:1,000), phosphorylated (p)-FAK (Y397; #3283,), β1 integrin (#9699,), Akt (#9272,), p-Akt (S473; #9271, 1:1,000), caspase 3 (#9662S), cleaved PARP (#9541), p44/42 MAPK (ERK1/2; #9107), p-p44/42 MAPK (Thr 202/Tyr 204; #9101), vimentin (#3390), N-cadherin (#5296), β-catenin (#8480), GAPDH (#2118) and E-cadherin (#3195) were purchased from Cell Signaling Technology (Beverly, MA, USA). Antibodies against cyclin A (sc-271682) and FAK (sc-558) were purchased from Santa Cruz Biotechnology Inc. (Dallas, TX, USA). Cisplatin was purchased from Sigma (St. Louis, MO, USA).

Copyright and License information:  ©2019 by the authors.
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A